BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 38103737)

  • 1. A multitrait genetic study of hemostatic factors and hemorrhagic transformation after stroke treatment.
    Gallego-Fabrega C; Temprano-Sagrera G; Cárcel-Márquez J; Muiño E; Cullell N; Lledós M; Llucià-Carol L; Martin-Campos JM; Sobrino T; Castillo J; Millán M; Muñoz-Narbona L; López-Cancio E; Ribó M; Alvarez-Sabin J; Jiménez-Conde J; Roquer J; Tur S; Obach V; Arenillas JF; Segura T; Serrano-Heras G; Marti-Fabregas J; Freijo-Guerrero M; Moniche F; Castellanos MDM; Morrison AC; Smith NL; de Vries PS; Fernández-Cadenas I; Sabater-Lleal M; ;
    J Thromb Haemost; 2024 Apr; 22(4):936-950. PubMed ID: 38103737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-phenotype analyses of hemostatic traits with cardiovascular events reveal novel genetic associations.
    Temprano-Sagrera G; Sitlani CM; Bone WP; Martin-Bornez M; Voight BF; Morrison AC; Damrauer SM; de Vries PS; Smith NL; Sabater-Lleal M
    J Thromb Haemost; 2022 Jun; 20(6):1331-1349. PubMed ID: 35285134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Hemostatic Profile and Migraine: A Mendelian Randomization Analysis.
    Guo Y; Rist PM; Sabater-Lleal M; de Vries P; Smith N; Ridker PM; Kurth T; Chasman DI
    Neurology; 2021 May; 96(20):e2481-e2487. PubMed ID: 33795393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Thyroid Function on Hemostasis, Coagulation, and Fibrinolysis: A Mendelian Randomization Study.
    Ellervik C; Mora S; Kuś A; Åsvold B; Marouli E; Deloukas P; Sterenborg RBTM; Teumer A; Burgess S; Sabater-Lleal M; Huffman J; Johnson AD; Trégouet DA; Smith NL; Medici M; DeVries PS; Chasman DI; Kjaergaard AD
    Thyroid; 2021 Sep; 31(9):1305-1315. PubMed ID: 34210154
    [No Abstract]   [Full Text] [Related]  

  • 5. Mendelian Randomization Analysis of Hemostatic Factors and Their Contribution to Peripheral Artery Disease-Brief Report.
    Small AM; Huffman JE; Klarin D; Sabater-Lleal M; Lynch JA; Assimes TL; Sun YV; Miller D; Freiberg MS; Morrison AC; Rader DJ; Wilson PWF; Cho K; Tsao PS; Chang KM; Smith NL; O'Donnell CJ; de Vries PS; Damrauer SM;
    Arterioscler Thromb Vasc Biol; 2021 Jan; 41(1):380-386. PubMed ID: 32847391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-Wide Association Transethnic Meta-Analyses Identifies Novel Associations Regulating Coagulation Factor VIII and von Willebrand Factor Plasma Levels.
    Sabater-Lleal M; Huffman JE; de Vries PS; Marten J; Mastrangelo MA; Song C; Pankratz N; Ward-Caviness CK; Yanek LR; Trompet S; Delgado GE; Guo X; Bartz TM; Martinez-Perez A; Germain M; de Haan HG; Ozel AB; Polasek O; Smith AV; Eicher JD; Reiner AP; Tang W; Davies NM; Stott DJ; Rotter JI; Tofler GH; Boerwinkle E; de Maat MPM; Kleber ME; Welsh P; Brody JA; Chen MH; Vaidya D; Soria JM; Suchon P; van Hylckama Vlieg A; Desch KC; Kolcic I; Joshi PK; Launer LJ; Harris TB; Campbell H; Rudan I; Becker DM; Li JZ; Rivadeneira F; Uitterlinden AG; Hofman A; Franco OH; Cushman M; Psaty BM; Morange PE; McKnight B; Chong MR; Fernandez-Cadenas I; Rosand J; Lindgren A; ; Gudnason V; Wilson JF; Hayward C; Ginsburg D; Fornage M; Rosendaal FR; Souto JC; Becker LC; Jenny NS; März W; Jukema JW; Dehghan A; Trégouët DA; Morrison AC; Johnson AD; O'Donnell CJ; Strachan DP; Lowenstein CJ; Smith NL
    Circulation; 2019 Jan; 139(5):620-635. PubMed ID: 30586737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of stroke patients receiving different doses of recombinant tissue plasminogen activator.
    Ong CT; Wong YS; Wu CS; Su YH
    Drug Des Devel Ther; 2017; 11():1559-1566. PubMed ID: 28572721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Which hemostatic markers add to the predictive value of conventional risk factors for coronary heart disease and ischemic stroke? The Caerphilly Study.
    Smith A; Patterson C; Yarnell J; Rumley A; Ben-Shlomo Y; Lowe G
    Circulation; 2005 Nov; 112(20):3080-7. PubMed ID: 16286603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma levels of tissue plasminogen activator/plasminogen activator inhibitor-1 complex and von Willebrand factor are significant risk markers for recurrent myocardial infarction in the Stockholm Heart Epidemiology Program (SHEEP) study.
    Wiman B; Andersson T; Hallqvist J; Reuterwall C; Ahlbom A; deFaire U
    Arterioscler Thromb Vasc Biol; 2000 Aug; 20(8):2019-23. PubMed ID: 10938026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lower androgenicity is associated with higher plasma levels of prothrombotic factors irrespective of age, obesity, body fat distribution, and related metabolic parameters in men.
    De Pergola G; De Mitrio V; Sciaraffia M; Pannacciulli N; Minenna A; Giorgino F; Petronelli M; Laudadio E; Giorgino R
    Metabolism; 1997 Nov; 46(11):1287-93. PubMed ID: 9361687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic influences on fibrinogen, tissue plasminogen activator-antigen and von Willebrand factor in males and females.
    de Lange M; de Geus EJ; Kluft C; Meijer P; van Doornen LJ; Boomsma DI; Snieder H
    Thromb Haemost; 2006 Mar; 95(3):414-9. PubMed ID: 16525567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extension of Tissue Plasminogen Activator Treatment Window by Granulocyte-Colony Stimulating Factor in a Thromboembolic Rat Model of Stroke.
    Dela Peña IC; Yang S; Shen G; Fang Liang H; Solak S; Borlongan CV
    Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29857523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inverse correlation between thyroid function and hemostatic markers for coronary heart disease in obese children and adolescents.
    Gallistl S; Sudi KM; Leschnik B; Muntean W; Borkenstein MH
    J Pediatr Endocrinol Metab; 2000; 13(9):1615-20. PubMed ID: 11154157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemostatic factors as predictors of ischemic heart disease and stroke in the Edinburgh Artery Study.
    Smith FB; Lee AJ; Fowkes FG; Price JF; Rumley A; Lowe GD
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3321-5. PubMed ID: 9409328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue plasminogen activator antigen is strongly associated with myocardial infarction in young women.
    Mannucci PM; Bernardinelli L; Foco L; Galli M; Ribichini F; Tubaro M; Peyvandi F
    J Thromb Haemost; 2005 Feb; 3(2):280-6. PubMed ID: 15670033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between fibrinogen-to-albumin ratio and hemorrhagic transformation after intravenous thrombolysis in ischemic stroke patients.
    Yang M; Tang L; Bing S; Tang X
    Neurol Sci; 2023 Apr; 44(4):1281-1288. PubMed ID: 36529794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Socioeconomic status and determinants of hemostatic function in healthy women.
    Wamala SP; Murray MA; Horsten M; Eriksson M; Schenck-Gustafsson K; Hamsten A; Silveira A; Orth-Gomér K
    Arterioscler Thromb Vasc Biol; 1999 Mar; 19(3):485-92. PubMed ID: 10073947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rosiglitazone ameliorates tissue plasminogen activator-induced brain hemorrhage after stroke.
    Li Y; Zhu ZY; Lu BW; Huang TT; Zhang YM; Zhou NY; Xuan W; Chen ZA; Wen DX; Yu WF; Li PY
    CNS Neurosci Ther; 2019 Dec; 25(12):1343-1352. PubMed ID: 31756041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 25-Hydroxyvitamin D and pre-clinical alterations in inflammatory and hemostatic markers: a cross sectional analysis in the 1958 British Birth Cohort.
    Hyppönen E; Berry D; Cortina-Borja M; Power C
    PLoS One; 2010 May; 5(5):e10801. PubMed ID: 20520739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide association study for circulating tissue plasminogen activator levels and functional follow-up implicates endothelial STXBP5 and STX2.
    Huang J; Huffman JE; Yamakuchi M; Trompet S; Asselbergs FW; Sabater-Lleal M; Trégouët DA; Chen WM; Smith NL; Kleber ME; Shin SY; Becker DM; Tang W; Dehghan A; Johnson AD; Truong V; Folkersen L; Yang Q; Oudot-Mellkah T; Buckley BM; Moore JH; Williams FM; Campbell H; Silbernagel G; Vitart V; Rudan I; Tofler GH; Navis GJ; Destefano A; Wright AF; Chen MH; de Craen AJ; Worrall BB; Rudnicka AR; Rumley A; Bookman EB; Psaty BM; Chen F; Keene KL; Franco OH; Böhm BO; Uitterlinden AG; Carter AM; Jukema JW; Sattar N; Bis JC; Ikram MA; ; Sale MM; McKnight B; Fornage M; Ford I; Taylor K; Slagboom PE; McArdle WL; Hsu FC; Franco-Cereceda A; Goodall AH; Yanek LR; Furie KL; Cushman M; Hofman A; Witteman JC; Folsom AR; Basu S; Matijevic N; van Gilst WH; Wilson JF; Westendorp RG; Kathiresan S; Reilly MP; ; Tracy RP; Polasek O; Winkelmann BR; Grant PJ; Hillege HL; Cambien F; Stott DJ; Lowe GD; Spector TD; Meigs JB; Marz W; Eriksson P; Becker LC; Morange PE; Soranzo N; Williams SM; Hayward C; van der Harst P; Hamsten A; Lowenstein CJ; Strachan DP; O'Donnell CJ;
    Arterioscler Thromb Vasc Biol; 2014 May; 34(5):1093-101. PubMed ID: 24578379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.